Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Mediators of Inflammation|July 4, 2014
Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trialTodd Hulgan, M Sean Boger, Diana H Liao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients: 24-week analysis from the RESIST-1 trialJoseph Gathe, David A Cooper, Charles Farthing, et al.
AIDS Research and Human Retroviruses|July 20, 2001
Improvement of HIV-specific immunity in HIV-infected twins treated with highly active antiretroviral therapy, interleukin 2, and syngeneic adoptively transferred cellsC M Tsoukas, H M Turner, G E Hatzakis, et al.
Journal of the International Association of Providers of AIDS Care|August 7, 2013
Self-Reported Preconception Care of HIV-Positive Women of Reproductive Potential: A Retrospective StudyMona R Loutfy, Sandra Blitz, Yimeng Zhang, et al.
The New England Journal of Medicine|August 8, 1996
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study GroupS D Shafran, J Singer, D P Zarowny, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2014
Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillanceStefan P Kuster, Wallis Rudnick, Altynay Shigayeva, et al.
Antiviral Research|January 2, 2007
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtideM R Loutfy, J M Raboud, J S G Montaner, et al.
HIV Medicine|September 1, 2007
A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administrationM R Loutfy, M Harris, J M Raboud, et al.
CMAJ Open|March 16, 2022
Neighbourhood-level material deprivation and response to combination antiretroviral therapy in the Canadian Observational Cohort (CANOC): a longitudinal cohort studyAlison R McClean, Jason Trigg, Monica Ye, et al.
Dermatology and Therapy|April 21, 2022
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert PanelKim A Papp, Jennifer Beecker, Curtis Cooper, et al.
Pageof 14